Senseonics Holdings Inc expected to post a loss of 62 cents a share - Earnings Preview
Senseonics Holdings Inc expected to post a loss of 62 cents a share - Earnings Preview
Senseonics Holdings Inc SENS.OQ SENS.O is expected to show a rise in quarterly revenue when it reports results on August 6 for the period ending June 30 2026
The Germantown Maryland-based company is expected to report a 93.6% increase in revenue to $12.871 million from $6.65 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.
LSEG's mean analyst estimate for Senseonics Holdings Inc is for a loss of 62 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy," 2 "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Senseonics Holdings Inc is $14.00, about 167.9% above its last closing price of $5.23
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | -0.68 | -0.68 | -0.71 | Missed | -4.9 |
Dec. 31 2026 | -0.44 | -0.43 | -0.47 | Missed | -8.2 |
Sep. 30 2025 | -0.17 | -0.28 | -0.43 | Missed | -53.6 |
Jun. 30 2025 | -0.40 | -0.40 | -0.40 | Met | 0 |
Mar. 31 2025 | -0.47 | -0.46 | -0.40 | Beat | 13 |
Dec. 31 2024 | -0.60 | -0.59 | -0.40 | Beat | 32.8 |
Sep. 30 2024 | -0.74 | -0.69 | -0.80 | Missed | -16.3 |
Jun. 30 2024 | -0.63 | -0.61 | -0.60 | Beat | 2.4 |
This summary was machine generated August 4 at 21:37 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Senseonics Holdings
See all newsDiabetes device firm Beta Bionics jumps after boosted $150 mln equity raise
Diabetes device firm Beta Bionics falls on $150 mln equity raise
Diabetes device firm Beta Bionics slides on $125 mln stock offering plans
Senseonics Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Senseonics Q2 revenue jumps, raises 2026 outlook